IL3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Integra Lifesciences Holdings Corp

Watchlist Manager

Watchlist

Price: 14.8 EUR Market Closed

Market Cap: €2.9B

I	Integra Lifesciences Holdings Corp XMUN:IL3	US
R	Ryder System Inc SWB:RYD	US
P	Pathfinder Ventures Inc F:RVF	CA
C	Cinemark Holdings Inc F:ZZA	US
M	Mitchells & Butlers PLC F:MABB	UK
W	Weng Fine Art AG F:WFA	DE
M	Medco Energi Internasional Tbk PT XMUN:MEF	ID
	IDNTT SA F:N7W	CH
R	Revance Therapeutics Inc F:RTI	US
S	StealthGas Inc F:S6W	GR
	Montrose Environmental Group Inc F:5MO	US
P	Public Power Corporation SA ATHEX:PPC	GR
B	Barnes & Noble Education Inc F:2BN	US
	Grupa Kety SA F:GQ2	PL

Profitability Summary

Integra Lifesciences Holdings Corp's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

63% > 57%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

19% > 11%

Negative Net Margin

-30%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

11% > -30%

Negative Free Cash Flow Margin

-1%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

13% > -1%

Negative ROE

-39%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.